Engineers Gate Manager LP Avadel Pharmaceuticals PLC Put Options Transaction History
Engineers Gate Manager LP
- $5.55 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AVDL
# of Institutions
6Shares Held
738KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL600KShares$5.84 Million3.14% of portfolio
-
Schulhoff & CO Inc138KShares$1.34 Million0.52% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$4,8700.0% of portfolio
-
American Research & Management Co.100Shares$9740.0% of portfolio
-
Exane Derivatives33Shares$3210.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $590M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...